Literature DB >> 18209468

Swelling-induced taurine transport: relationship with chloride channels, anion-exchangers and other swelling-activated transport pathways.

David B Shennan1.   

Abstract

Cells have to regulate their volume in order to survive. Moreover, it is now evident that cell volume per se and the membrane transport processes which regulate it, comprise an important signalling unit. For example, macromolecular synthesis, apoptosis, cell growth and hormone secretion are all influenced by the cellular hydration state. Therefore, a thorough understanding of volume-activated transport processes could lead to new strategies being developed to control the function and growth of both normal and cancerous cells. Cell swelling stimulates the release of ions such as K(+) and Cl(-) together with organic osmolytes, especially the beta-amino acid taurine. Despite being the subject of intense research interest, the nature of the volume-activated taurine efflux pathway is still a matter of controversy. On the one hand it has been suggested that osmosensitive taurine efflux utilizes volume-sensitive anion channels whereas on the other it has been proposed that the band 3 anion-exchanger is a swelling-induced taurine efflux pathway. This article reviews the evidence for and against a role of anion channels and exchangers in osmosensitive taurine transport. Furthermore, the distinct possibility that neither pathway is involved in taurine transport is highlighted. The putative relationship between swelling-induced taurine transport and volume-activated anionic amino acid, alpha-neutral amino acid and K(+) transport is also examined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209468     DOI: 10.1159/000113743

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  17 in total

Review 1.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

Review 2.  Volume-dependent osmolyte efflux from neural tissues: regulation by G-protein-coupled receptors.

Authors:  Stephen K Fisher; Tooba A Cheema; Daniel J Foster; Anne M Heacock
Journal:  J Neurochem       Date:  2008-06-02       Impact factor: 5.372

Review 3.  VRACs and other ion channels and transporters in the regulation of cell volume and beyond.

Authors:  Thomas J Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

Review 4.  Cholesterol and ion channels.

Authors:  Irena Levitan; Yun Fang; Avia Rosenhouse-Dantsker; Victor Romanenko
Journal:  Subcell Biochem       Date:  2010

5.  Molecular composition and heterogeneity of the LRRC8-containing swelling-activated osmolyte channels in primary rat astrocytes.

Authors:  Alexandra L Schober; Corinne S Wilson; Alexander A Mongin
Journal:  J Physiol       Date:  2017-09-12       Impact factor: 5.182

6.  Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus.

Authors:  Keiko Kanamori; Brian D Ross
Journal:  Epilepsy Res       Date:  2013-09-01       Impact factor: 3.045

Review 7.  Biophysics and Physiology of the Volume-Regulated Anion Channel (VRAC)/Volume-Sensitive Outwardly Rectifying Anion Channel (VSOR).

Authors:  Stine F Pedersen; Yasunobu Okada; Bernd Nilius
Journal:  Pflugers Arch       Date:  2016-01-06       Impact factor: 3.657

8.  Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells.

Authors:  Daniel J Foster; Victor M Vitvitsky; Ruma Banerjee; Anne M Heacock; Stephen K Fisher
Journal:  J Neurochem       Date:  2008-10-08       Impact factor: 5.372

Review 9.  VRAC: molecular identification as LRRC8 heteromers with differential functions.

Authors:  Thomas J Jentsch; Darius Lutter; Rosa Planells-Cases; Florian Ullrich; Felizia K Voss
Journal:  Pflugers Arch       Date:  2015-12-03       Impact factor: 3.657

Review 10.  Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics.

Authors:  Umberto Banderali; Luigi Leanza; Najmeh Eskandari; Saverio Gentile
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.